FTX and cancer: Furthermore, in the analysis for the prognostic role of FTX in cancer including 4668 patients with high FTX expression and 4691 patients with low FTX expression, the results indicated that the higher expression of FTX was significantly associated with lower OS (p < 0.05) and DFS of cancer (p < 0.05), suggesting that the FTX can be used as a prognostic biomarker for cancers.